Cargando…
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum androgens and the inhibition of androgen receptor (AR) is generally the first therapy adopted. However, the patient’s response to androg...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763510/ https://www.ncbi.nlm.nih.gov/pubmed/33321757 http://dx.doi.org/10.3390/cells9122653 |